BERRINO, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 533
EU - Europa 430
AS - Asia 105
SA - Sud America 4
AF - Africa 3
OC - Oceania 1
Totale 1.076
Nazione #
US - Stati Uniti d'America 526
IT - Italia 202
IE - Irlanda 79
SE - Svezia 68
SG - Singapore 52
IN - India 49
FI - Finlandia 28
DE - Germania 13
FR - Francia 13
RO - Romania 11
GB - Regno Unito 7
CA - Canada 6
UA - Ucraina 6
CL - Cile 2
IR - Iran 2
NL - Olanda 2
AR - Argentina 1
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
CI - Costa d'Avorio 1
MX - Messico 1
PH - Filippine 1
SC - Seychelles 1
TG - Togo 1
TR - Turchia 1
Totale 1.076
Città #
Ashburn 110
Rome 81
Dublin 79
Fairfield 60
Chandler 34
Millbury 30
Princeton 27
Helsinki 26
Houston 26
Naples 26
New York 20
San Diego 20
Singapore 19
Washington 19
Salerno 18
Wilmington 15
Cambridge 14
Woodbridge 12
Piedimonte 10
Andover 9
Seattle 9
Pessac 8
Ann Arbor 7
Latina Scalo 5
Toronto 5
Mannheim 4
Bozzolo 3
Chennai 3
Dearborn 3
Florence 3
Padova 3
Portici 3
Sermoneta 3
Aversa 2
Berlin 2
Bonn 2
Cassino 2
Chieti 2
Dordrecht 2
Genoa 2
Irpin 2
Laurel 2
Lawrence 2
Norwalk 2
Paris 2
San Paolo di Civitate 2
Senigallia 2
Talence 2
Tehran 2
Abidjan 1
Acton 1
Araguari 1
Boardman 1
Boston 1
Boydton 1
Buffalo 1
Bühl 1
Caloocan City 1
Chico 1
Clearwater 1
Columbus 1
Coominya 1
Federal 1
Fonte Nuova 1
Frankfurt am Main 1
Fremont 1
Hyderabad 1
Kiev 1
Lappeenranta 1
Las Vegas 1
Lomé 1
London 1
Marano di Napoli 1
Mexico City 1
Milan 1
Montelibretti 1
Munich 1
Napoli 1
New Bedfont 1
Oxford 1
Plano 1
Pontelandolfo 1
Provo 1
Redmond 1
Reggio Calabria 1
San Giovanni Rotondo 1
San Mateo 1
Sofia 1
Stockholm 1
Trumbull 1
Totale 787
Nome #
Novel analogues of Temporin L and their potential therapeutic application 106
Novel Insights on Human Carbonic Anhydrase Inhibitors Based on Coumalic Acid: Design, Synthesis, Molecular Modeling Investigation, and Biological Studies 60
A novel class of dual-acting DCH-CORMs counteracts oxidative stress-induced inflammation in human primary tenocytes 47
Novel Insights on CAI–CORM Hybrids: Evaluation of the CO Releasing Properties and Pain-Relieving Activity of Differently Substituted Coumarins for the Treatment of Rheumatoid Arthritis 41
Carbonic anhydrase inhibitors of different structures dilate pre-contracted porcine retinal arteries 36
Dual carbonic anhydrase ix/xii inhibitors and carbon monoxide releasing molecules modulate LPS-mediated inflammation in mouse macrophages 36
Modulating the Efficacy of Carbonic Anhydrase Inhibitors through Fluorine Substitution. 36
Azidothymidine "clicked" into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors 35
Bioorganometallic derivatives of 4-hydrazino-benzenesulfonamide as carbonic anhydrase inhibitors: Synthesis, characterization and biological evaluation 35
In silico identification and biological evaluation of antioxidant food components endowed with IX and XII hCA inhibition 35
Novel sulfamide-containing compounds as selective carbonic anhydrase i inhibitors 35
Carbonic anhydrase inhibitors for the treatment of epilepsy and obesity 33
Toxicity evaluation of sulfamides and coumarins that efficiently inhibit human carbonic anhydrases 33
In Silico-Guided Identification of New Potent Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae. 33
N-aryl-N′-ureido-O-sulfamates as potent and selective inhibitors of hCA VB over hCA VA: Deciphering the binding mode of new potential agents in mitochondrial dysfunctions 32
New thiopyrimidine-benzenesulfonamide conjugates as selective carbonic anhydrase II inhibitors: synthesis, in vitro biological evaluation, and molecular docking studies. 31
4-Substituted benzenesulfonamides incorporating bi/tricyclic moieties act as potent and isoform-selective carbonic anhydrase II/IX inhibitors 31
Inhibition of α-, β-, γ-, and δ-carbonic anhydrases from bacteria and diatoms with N'-aryl-N-hydroxy-ureas 31
1,2,4-Trisubstituted imidazolinones with dual carbonic anhydrase and p38 mitogen-activated protein kinase inhibitory activity. 29
Synthesis and carbonic anhydrase inhibitory properties of novel 4-(2-aminoethyl)benzenesulfonamide-dipeptide conjugates 29
Advances in microwave-assisted synthesis and the impact of novel drug discovery 29
A Class of Carbonic Anhydrase IX/XII - Selective Carboxylate Inhibitors 28
An innovative spectroscopic approach for qualitative and quantitative evaluation of Mb-CO from myoglobin carbonylation reaction through chemometrics methods 28
Zeta-carbonic anhydrases show CS2 hydrolase activity: A new metabolic carbon acquisition pathway in diatoms? 27
New sulfonamides containing organometallicacylhydrazones: synthesis, characterisation and biological evaluation as inhibitors of human carbonic anhydrases 25
Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and Vibrio cholerae α- and β-class enzymes 24
Amine-and amino acid-based compounds as carbonic anhydrase activators 24
Novel approaches for designing drugs that interfere with pH regulation 23
Synthesis and evaluation of carbonic anhydrase inhibitors with carbon monoxide releasing properties for the management of rheumatoid arthritis 21
null 21
SLC-0111 enaminone analogs, 3/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX 20
New 1 H ‐indole‐2,3‐dione 3‐thiosemicarbazones with 3‐sulfamoylphenyl moiety as selective carbonic anhydrase inhibitors 19
Rho-kinase inhibitors in the management of glaucoma 18
A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration 15
Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies 12
null 6
Mechanisms of the Antiproliferative and Antitumor Activity of Novel Telomerase-Carbonic Anhydrase Dual-Hybrid Inhibitors 3
Totale 1.127
Categoria #
all - tutte 4.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.453


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 1 0 0 0 0 2 1 0 0 0 0 0
2020/202195 0 0 0 1 0 3 0 0 0 0 0 91
2021/2022265 53 2 2 12 40 26 5 8 11 27 41 38
2022/2023332 54 9 12 21 44 80 29 18 35 4 20 6
2023/2024415 8 19 33 58 55 78 7 55 16 27 46 13
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 1.127